Dennis Bastas’ net worth emerges from entrepreneurship. He is an Australian businessman who is the Chairman and Group CEO of DBG Health, a leading provider of health and wellbeing solutions.
Dennis Bastas net worth
The estimated Dennis Bastas net worth is $3.7 billion as of 22 September 2026, according to Forbes. His multi-billion-dollar wealth is derived from DBG Health and its parent business, DBG Global Enterprises, alongside the value created through pharmaceutical acquisitions, consumer beauty brands and other healthcare investments.
Occupation overview
Dennis Bastas is a pharmaceutical executive best known as the Chairman and Group CEO of DBG Health, a diversified healthcare and consumer products group with interests in pharmaceuticals, consumer health, beauty, and healthcare services.
He began his career in logistics at Coles Myer before working at Village Roadshow and pursuing entrepreneurial opportunities. His early experience in supply chains and business operations helped shape his approach to building companies.
He entered the pharmaceutical industry after identifying an opportunity to expand access to affordable generic medicines in Australia. In 2003, he helped establish Genepharm Australasia, which later became Ascent Pharmahealth. Despite facing business challenges, the company grew into a significant supplier of generic medicines and was acquired by US pharmaceutical company Watson Pharmaceuticals in 2012 in a deal reported at approximately $375 million.
The transaction marked a major milestone in his career and provided capital for further investments in the pharmaceutical sector.
In 2015, Dennis Bastas and his business partner acquired Arrow Pharmaceuticals for approximately $380 million. He subsequently served as its Executive Chairman before overseeing its 2019 merger with Apotex Australia, creating Arrotex Pharmaceuticals.
As Chairman and CEO of Arrotex from 2019 to 2023, he helped expand the company into one of Australia’s largest pharmaceutical businesses, with a substantial presence in the generic medicines market.
Its portfolio has included businesses such as Arrow Pharmaceuticals, Apotex Australia, Oraderm Pharmaceuticals and MyPak Solutions.
Beyond pharmaceuticals, Dennis Bastas has expanded into consumer health, wellness and beauty through DBG Health’s subsidiary VidaCorp, whose portfolio includes MCoBeauty, Nude by Nature, PONi Cosmetics and other retail brands.
The strategy centres on offering affordable alternatives to established premium products and distributing them through major retail chains.
He has also maintained leadership interests in Juno Pharmaceuticals and myDNA, the latter focusing on genetics-based health solutions.
Since becoming Chairman and Group CEO of DBG Health in 2023, he has continued to consolidate the group’s businesses, pursue acquisitions and expand its international presence.
DBG Health’s principal operations include Arrotex Pharmaceuticals, VidaCorp, AXE Health Services, Independent Pharmacies of Australia Group and myDNA.
One of his most significant business achievements came in August 2025, when global investment firm BDT & MSD Partners made a substantial minority investment in DBG Health.
The transaction was reported at approximately A$1.6 billion and valued the company at around A$7 billion, providing capital for international expansion and future acquisitions. The deal demonstrated the scale of the healthcare and beauty empire he had built while allowing him to retain a significant ownership stake and strategic influence.
Recognitions
- Forbes Billionaires – Healthcare (2026)
- Forbes Australia’s 50 Richest – Healthcare (2026)
- Financial Review Business People of the Year (2025)
Conclusion on Dennis Bastas net worth
In conclusion, Dennis Bastas’ wealth comes primarily from his ownership interests in DBG Health and its subsidiary. His business achievements include building a major Australian pharmaceutical group, completing significant mergers and acquisitions, securing a multibillion-dollar investment and expanding Australian consumer brands into overseas markets.
Featured image: Dennis Bastas on dbghealth.com.au
If you like our work, you can buy us a soda
Buy us a soda 🥤
